HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig.

Abstract
The hemodynamic and antithrombotic action of ZK 36374, a stable carbacyclin derivative of prostacyclin, was studied during electrically-induced coronary artery thrombosis in the open chest anesthetized pig. Infusion of ZK 36374 (100 ng/kg/min, n = 6) had no effect on heart rate and cardiac output, but caused a 20% reduction in mean arterial blood pressure by peripheral vasodilation. In animals receiving solvent or no drug prior to thrombosis induction, the time to occlusive coronary artery thrombosis (TOT) was 30 +/- 2 minutes (mean +/- SEM, n = 17). Pretreatment with an i.v. infusion of ZK 36374 (100 ng/kg/min) prolonged TOT by 50% to 47 +/- 7 minutes (p less than 0.005, n = 6). This prolongation of TOT was not due to the lower blood pressure in the ZK 36374 group, as dihydralazine in a dose that lowered arterial blood pressure to the same extent had no effect on TOT (32 +/- 4 minutes, n = 4). The results indicate that ZK 36374 may be useful in delaying (or preventing) occlusive coronary artery thrombi.
AuthorsW J van der Giessen, W J Mooi, A M Rutteman, L Berk, P D Verdouw
JournalThrombosis research (Thromb Res) Vol. 36 Issue 1 Pg. 45-51 (Oct 01 1984) ISSN: 0049-3848 [Print] United States
PMID6209820 (Publication Type: Journal Article)
Chemical References
  • Cardiotonic Agents
  • Fibrinolytic Agents
  • Epoprostenol
  • Iloprost
Topics
  • Animals
  • Arterial Occlusive Diseases (physiopathology)
  • Cardiotonic Agents (pharmacology)
  • Coronary Disease (blood, drug therapy, physiopathology)
  • Disease Models, Animal
  • Epoprostenol (pharmacology)
  • Fibrinolytic Agents (pharmacology)
  • Hemodynamics (drug effects)
  • Iloprost
  • Platelet Aggregation (drug effects)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: